financetom
Business
financetom
/
Business
/
Spyware firm NSO looking to shut down Pegasus unit, sell company, says report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Spyware firm NSO looking to shut down Pegasus unit, sell company, says report
Dec 14, 2021 3:28 AM

The NSO Group, the Israeli cyber security firm that's known for its controversial Pegasus unit, is looking to sell the entire company and shut down operations, reported Bloomberg, citing people familiar with the matter.

The company, which has been embroiled in scandals and lawsuits, is at the risk of defaulting on its debts, said the report, adding that it has been in talks with investment funds for either refinancing its existing debt, or barring that an outright sale.

According to the report, two US-based funds that are in the running to take over the company have already discussed shutting down the Pegasus unit. In return, they'll be investing $200 million in the company to turn Pegasus into a strictly defense-oriented cyber security service, it said.

The notorious spyware allowed clients of NSO, which the company claims to be legitimate governments, to comprehensively spy on their targets. Once on a mobile device through an unsecured link or dropped WhatsApp video call, even encrypted messaging apps are not secure. Pegasus sees messages, tracks call logs, user activity through apps, gathers location data of the device, can access the camera, and listen in through the microphone.

>>Pegasus row: How much does it cost to use the spyware?

However instead of terror threats, recent journalistic investigations found that NSO clients were using the spyware to keep tabs on political opponents, human rights activists, lawyers and journalists.

The Pegasus Project, as the investigation was named, alleged that in India the spyware was used to spy on ministers, opposition leaders, political strategists and tacticians, journalists, activists, minority leaders, Supreme Court judges, religious leaders, administrators like Election Commissioners and heads of Central Bureau of Investigation (CBI).

In response to the allegations, the Supreme Court of India ordered an independent probe in the matter in October.

The group has a debt of about $450 million. The company had been bailed out by a management buyout just two years ago which saw it being valued at nearly $1 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Ecuador reopens mining concession registry after seven years
Ecuador reopens mining concession registry after seven years
Jun 16, 2025
QUITO (Reuters) -Ecuador's mining ministry announced on Monday the launch of a new registry of concessions for the first time in seven years in an effort to attract more mining projects to the South American country and curb illegal operations. The prior registry was shut down in 2018 over concerns of irregularities in the concession system, and no new concessions...
Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports
Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports
Jun 16, 2025
June 16 (Reuters) - Eli Lilly ( LLY ) is in advanced talks to acquire gene editing startup Verve Therapeutics ( VERV ) for up to $1.3 billion, aiming to strengthen its pipeline of experimental medicines, the Financial Times reported on Monday. The drug maker's acquisition bid includes a payment of almost $1 billion upfront for Verve, and a further...
Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports
Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports
Jun 16, 2025
(Reuters) -Eli Lilly ( LLY ) is in advanced talks to acquire gene editing startup Verve Therapeutics ( VERV ) for up to $1.3 billion, aiming to strengthen its pipeline of experimental medicines, the Financial Times reported on Monday. The drug maker's acquisition bid includes a payment of almost $1 billion upfront for Verve, and a further $300 million based...
Copyright 2023-2026 - www.financetom.com All Rights Reserved